Abdulaali R. Almutairi
Abdulaali R. Almutairi publishes mostly in Oncology, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Cancer Immunotherapy and Biomarkers, Atrial Fibrillation Management and Outcomes and Venous Thromboembolism Diagnosis and Management.
- World rank
- #1,216,609 of 7,710,434 ranked researchers
- Rank in United States
- #389,735 of 1,627,098
- Works
- 67
- Citations
- 950
- Citations per work
- 14.2
What does Abdulaali R. Almutairi research?
Abdulaali R. Almutairi's work is mostly in Medicine (40%), Economics, Econometrics and Finance (8%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3247.4%
- Health Sciences2740.0%
- Medicine2740.0%
- Social Sciences57.9%
- Life Sciences34.7%
- 1Oncology16% of their works
- 2Cardiology and Cardiovascular Medicine10% of their works
- 3Surgery8% of their works
- 4Economics and Econometrics8% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Molecular Biology5% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Melanoma and MAPK Pathways
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Diabetes Treatment and Management
- Biosimilars and Bioanalytical Methods
Which keywords describe Abdulaali R. Almutairi's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Anticoagulant Therapy, Antithrombotic Therapy, Atrial Fibrillation, Venous Thromboembolism, BRAF gene and Cost-effectiveness Analysis.
- Immunogenicity
- Type 2 Diabetes
- Quality of Life
- Generic Drugs
- Cost-effectiveness Analysis
- Venous Thromboembolism
- Antithrombotic Therapy
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Anticoagulant Therapy
- Atrial Fibrillation
- BRAF gene
- Drug Development Costs
- MAP Kinase
- Cardiovascular Outcomes
- Biosimilars
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- Anticoagulant Therapy71 topic
- Antithrombotic Therapy71 topic
- Atrial Fibrillation71 topic
- Venous Thromboembolism71 topic
- BRAF gene61 topic
- Cost-effectiveness Analysis61 topic
- Drug Development Costs61 topic
- Generic Drugs61 topic
- MAP Kinase61 topic
- Quality of Life61 topic
- Cardiovascular Outcomes51 topic
- Type 2 Diabetes51 topic
- Biosimilars41 topic
- Immunogenicity41 topic
Where does Abdulaali R. Almutairi work?
Abdulaali R. Almutairi's main affiliation in the publication record is University of Arizona, United States.
How many publications and citations does Abdulaali R. Almutairi have?
OpenAlex counts 67 works and 950 citations for Abdulaali R. Almutairi, an h-index of 12, ranking #1,216,609 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Abdulaali R. Almutairi. Posts are plain text and can be reported.